---
title: "Telmisartan Tablets, USP 40mg, Rx Only, 30 Tablets per bottle, Manufactured b... — FDA record D-0388-2024 | Is It on Recall"
description: "Failed Stability Specifications: Out of specification for blend uniformity."
url: https://isitonrecall.com/recall/fda-drug-d-0388-2024-telmisartan-tablets-usp-40mg-rx-only-30-tablets-per-bottle-manufactured-by-micro-labs-limited-goa-40/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA drug enforcement

# Telmisartan Tablets, USP 40mg, Rx Only, 30 Tablets per bottle, Manufactured by: Micro Labs Limited Goa-403 722, INDIA... — FDA record D-0388-2024

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Feb 9, 2024. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: Telmisartan Tablets, USP 40mg, Rx Only, 30 Tablets per bottle, Manufactured by: Micro Labs Limited Goa-403 722, INDIA, Manufactured for: Micro Labs USA Inc., Somerset, NJ 08873, NDC 42571-227-30.
- **Reason**: Failed Stability Specifications: Out of specification for blend uniformity.
- **Classification**: Class II
- **Recalling firm**: Micro Labs Limited
- **Quantity**: 118,080 bottles
- **Agency-reported status**: Terminated
- **Source record identifier**: D-0388-2024

[Open the official record](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0388-2024%22)

[What the recall classes mean](https://isitonrecall.com/guides/recall-classes/). Classification is an agency assessment, not individual medical advice.

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | Lot #s: SFBG024, SFBG025, Exp. 05/31/2024 |

Match all identifying details in the current notice. A brand name alone is not enough.

## Distribution

Puerto Rico, TN, RI

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

- [Rhode Island](https://isitonrecall.com/state/rhode-island/)
- [Tennessee](https://isitonrecall.com/state/tennessee/)

## Dates in the source

- **Report date**: Mar 20, 2024
- **Recall initiation date**: Feb 9, 2024
- **Center classification date**: Mar 14, 2024
- **Termination date**: Jun 24, 2025

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Read the official notice for the action that applies to your exact product.

[Read the current instructions](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0388-2024%22)

## Before changing a medicine

Follow urgent instructions in the current official recall notice. Speak to your pharmacist or prescriber before stopping or changing a prescribed medicine.

Talk to your doctor or pharmacist if you have questions or concerns about your medicine. [FDA medication recall guidance](https://www.fda.gov/drugs/drug-recalls/understanding-drug-recalls-what-know-and-what-do)

## Related records

[Medications records](https://isitonrecall.com/category/medications/) [Micro Labs Limited records](https://isitonrecall.com/brand/micro-labs-limited/)
